Determinants of the Cost of Illness in Iranian Prostate Cancer Patients
Prostate Cancer · 2026-01 · 2026 (1)
DOI: 10.1155/proc/2149782 ↗Kurz gefasst
Fachartikel in der Zeitschrift Prostate Cancer, online erschienen am 15.04.2026. Verfasst von Ramin Ravangard und 5 weiteren Autor:innen. Beteiligte Einrichtung: Health Human Resources Research Center, School of Health Management and Information Sciences, Shiraz University of Medical Sciences, Shiraz, Iran, su…. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shiraz University of Medical Sciences.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
Prostate cancer (PCa) ranks as the fourth most prevalent form of cancer overall and imposes a substantial financial burden on individuals and communities. Given information on the costs of this disease and the factors influencing them, the present study analyzed factors affecting the costs of medical and nonmedical services for patients with PCa in southern Iran.
Methods
Factors affecting the cost of PCa were identified through a scoping review of international databases (ISI Web of Science, Scopus, PubMed, ProQuest, Magiran, and SID) and consultation with PCa experts. Subsequently, data on 254 PCa patients were collected between March 2020 and March 2022 using a two‐stage stratified random sampling method. Patients were randomly selected from the provincial Cancer Registry Center lists within strata defined by healthcare catchment areas. Multiple regression analysis using SPSS 13.0 was employed to determine the factors influencing costs.
Results
The findings from the multiple regression analysis indicated that premature mortality, grade, and monthly income (all p value < 0.001) were important factors affecting PCa patients’ costs.
Conclusions
In line with the results, implementing low‐cost screening systems for early detection and effective treatment of PCa at all income levels, and directing targeted subsidies to the health sector, especially to low‐income patients, can help reduce costs for PCa patients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Health Human Resources Research Center, School of Health Management and Information Sciences, Shiraz University of Medical Sciences, Shiraz, Iran, sums.ac.ir.
- Non-Communicable Diseases Research Center, Department of Epidemiology, School of Health, Shiraz University of Medical Sciences, Shiraz, Iran, sums.ac.ir.
- Department of Urology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran, sums.ac.ir.
ORCID-Profile: Ramin Ravangard, Faride Sadat Jalali
Förderung
- Shiraz University of Medical Sciences
Zitieren
APA
Ravangard, R., Keshavarz, K., Seif, M., Zeighami, S., Jafari, A., & Jalali, F. S. (2026). Determinants of the Cost of Illness in Iranian Prostate Cancer Patients. Prostate Cancer, 2026(1). https://doi.org/10.1155/proc/2149782
Vancouver
Ravangard R, Keshavarz K, Seif M, Zeighami S, Jafari A, Jalali FS. Determinants of the Cost of Illness in Iranian Prostate Cancer Patients. Prostate Cancer. 2026;2026(1). doi:10.1155/proc/2149782
BibTeX
@article{Ravangard2026,
author = {Ravangard, Ramin and Keshavarz, Khosro and Seif, Mozhgan and Zeighami, Shahryar and Jafari, Abdosaleh and Jalali, Faride Sadat},
title = {Determinants of the Cost of Illness in Iranian Prostate Cancer Patients},
journal = {Prostate Cancer},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/proc/2149782}
}
EUVIMED